Article
Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci.
Antimicrobial agents and chemotherapy - 1 Aug 2000
Guerin F, Varon E, Hoï A B, Gutmann L, Podglajen I
Abstract excerpt
Oropharyngeal samples from 60 hospitalized patients (30 fluoroquinolone [FQ]-treated and 30 non-FQ-treated patients) and 30 untreated nonhospitalized healthy control subjects yielded 20 isolates of viridans group streptococci with reduced susceptibility to FQ, mostly from the hospitalized patients. An efflux phenotype was commonly encountered, expressed either alone or with topoisomerase mutations. Interspecies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
